Literature DB >> 22634451

Vaccination against viral hepatitis of HIV-1 infected patients.

Bao-Chau Phung1, Odile Launay.   

Abstract

Reciprocal interactions between HIV and HAV or HBV can increase risk of morbidity and mortality in HIV disease and/or worsened the natural course of the hepatitis viruses. Hepatitis A vaccination is recommended for HIV infected patients at risk for exposure or severe disease: men who have sex with men, injecting drug users, patients with chronic liver disease and patients traveling in high endemic countries. As for healthy adults the scheme of vaccination is two doses 6 or 12 mo apart, nevertheless, seroconversion rates are lower. A third dose could improve the seroconversion rates. Hepatitis B vaccination is recommended for all HIV infected persons lacking prior immunity. As the immune response to hepatitis B vaccines is impaired in HIV-infected adults, four double doses of hepatitis B vaccine could enhance serological response. To assume a higher immune response, vaccines should be administered in HIV-infected patients with undetectable HIV viral load and high CD4 cell count.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22634451     DOI: 10.4161/hv.19105

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  5 in total

Review 1.  Immunization of children with secondary immunodeficiency.

Authors:  Susanna Esposito; Elisabetta Prada; Mara Lelii; Luca Castellazzi
Journal:  Hum Vaccin Immunother       Date:  2015-07-15       Impact factor: 3.452

2.  Prevention of Hepatitis A Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2020.

Authors:  Noele P Nelson; Mark K Weng; Megan G Hofmeister; Kelly L Moore; Mona Doshani; Saleem Kamili; Alaya Koneru; Penina Haber; Liesl Hagan; José R Romero; Sarah Schillie; Aaron M Harris
Journal:  MMWR Recomm Rep       Date:  2020-07-03

Review 3.  Hepatitis B and A vaccination in HIV-infected adults: A review.

Authors:  G Mena; A L García-Basteiro; J M Bayas
Journal:  Hum Vaccin Immunother       Date:  2015-07-24       Impact factor: 3.452

4.  Hepatitis A outbreak in HIV-infected MSM and in PrEP-using MSM despite a high level of immunity, Lyon, France, January to June 2017.

Authors:  Caroline Charre; Christophe Ramière; Anne-Marie Roque-Afonso; Christian Chidiac; Fabien Zoulim; Matthieu Godinot; Joseph Koffi; Caroline Scholtès; Jean-Michel Livrozet; Laurent Cotte
Journal:  Euro Surveill       Date:  2017-11

5.  Hepatitis A vaccination.

Authors:  Li Zhang
Journal:  Hum Vaccin Immunother       Date:  2020-07-10       Impact factor: 3.452

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.